Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Reading LevelReading Level
-
Content TypeContent Type
-
YearFrom:-To:
-
More FiltersMore FiltersItem TypeIs Full-Text AvailableSubjectPublisherSourceDonorLanguagePlace of PublicationContributorsLocation
Done
Filters
Reset
19
result(s) for
"Drugs Marketing Moral and ethical aspects"
Sort by:
Food politics
2013
We all witness, in advertising and on supermarket shelves, the fierce competition for our food dollars. In this engrossing exposé, Marion Nestle goes behind the scenes to reveal how the competition really works and how it affects our health. The abundance of food in the United States--enough calories to meet the needs of every man, woman, and child twice over--has a downside. Our over-efficient food industry must do everything possible to persuade people to eat more--more food, more often, and in larger portions--no matter what it does to waistlines or well-being. Like manufacturing cigarettes or building weapons, making food is big business. Food companies in 2000 generated nearly
Comfortably numb : how psychiatry is medicating a nation
Public perceptions of mental health issues have changed dramatically over the last fifteen years, and nowhere more than in the rampant overmedication of ordinary Americans. In 2006, 227 million antidepressant prescriptions were dispensed in the United States, more than any other class of medication; that year, the United States accounted for 66% of the global market. Here, psychiatrist Barber provides a context for this disturbing phenomenon. He explores the ways in which pharmaceutical companies first create the need for a drug and then rush to fill it, and he reveals the increasing pressure Americans are under to medicate themselves. Most importantly, he argues that without an industry to promote them, non-pharmaceutical approaches that could have the potential to help millions are tragically overlooked by a nation that sees drugs as an instant cure for all emotional difficulties.--From publisher description.
Profits before people? : ethical standards and the marketing of prescription drugs
by
Weber, Leonard J.
in
Criticism
,
Drug Industry -- economics -- United States
,
Drug Industry -- ethics -- United States
2006
The pharmaceutical industry has come under intense criticism in recent
years. One poll found that 70% of the sample agreed that drug companies put profits
ahead of people. Is this perception accurate? Have drug companies traded ethics for
profits and placed people at risk? In Profits before People?
Leonard J. Weber exposes pharmaceutical industry practices that have raised ethical
concerns. Providing systematic ethical analysis and reflection, he discusses such
practices as compensating physicians for serving as speakers or consultants,
providing incentives to physicians to enroll patients as subjects in clinical
research, and advertising prescription drugs to the public through the mass media.
Weber's critique of the industry is stern. While acknowledging that new industry
guidelines are promising, he finds much room for improvement in the way drug
companies market their products. Yet Weber makes a strong case that profits and
ethics can coexist and that they are not mutually exclusive. In an
effort to understand the proper place of commerce in disseminating information about
new drugs, the book aims to clarify basic responsibilities and to help identify
sound ethical practices. It recognizes that ethics and law are not the same, that
having a right is different from doing the right thing, and
that taking ethics seriously means recognizing that the law does not answer all
questions about what is right. Weber points the way to more demanding standards and
better practices that might begin to restore confidence in the drug
industry.
Windows into the soul : surveillance and society in an age of high technology
2016
We live in an age saturated with surveillance. Our personal and public lives are increasingly on display for governments, merchants, employers, hackers—and the merely curious—to see. In Windows into the Soul, Gary T. Marx, a central figure in the rapidly expanding field of surveillance studies, argues that surveillance itself is neither good nor bad, but that context and comportment make it so.
In this landmark book, Marx sums up a lifetime of work on issues of surveillance and social control by disentangling and parsing the empirical richness of watching and being watched. Using fictional narratives as well as the findings of social science, Marx draws on decades of studies of covert policing, computer profiling, location and work monitoring, drug testing, caller identification, and much more, Marx gives us a conceptual language to understand the new realities and his work clearly emphasizes the paradoxes, trade-offs, and confusion enveloping the field. Windows into the Soul shows how surveillance can penetrate our social and personal lives in profound, and sometimes harrowing, ways. Ultimately, Marx argues, recognizing complexity and asking the right questions is essential to bringing light and accountability to the darker, more iniquitous corners of our emerging surveillance society.
For more information, please see www.garymarx.net [http://www.garymarx.net].
Pharmageddon
2012
This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. He concludes with suggestions for reform of our currently corrupted evidence-based medical system.
The Power of Pills
by
Jillian Clare Cohen, Patricia Illingworth, Udo Schuklenk, Jillian Clare Cohen, Patricia Illingworth, Udo Schuklenk
in
Drug development
,
Moral and ethical aspects
,
Pharmaceutical industry
2006
Why does one-third of the global population not have access to essential medicines? What drives new drug research priorities? How do we manage the ethical, legal and social challenges associated with improving drug access? Answering these questions and more, this book is one of the first comprehensive and critical guides to global pharmaceutical policy issues.
This multidisciplinary book covers core issues in clear, short chapters. It is a one-stop resource for students, policy makers and academics. Bringing together the insights of over thirty different specialists from around the world, this book discusses:
- current regulation of the industry
- ethical issues in developing and distributing drugs
- how it prices and markets drugs
- recommendations on how to improve pharmaceutical policy
- the importance of pharmaceuticals
- the structure of the pharmaceutical industry
- what drugs are needed on a world wide scale
The Illusion of Evidence-Based Medicine
2020
An expose of the corruption of medicine by the pharmaceutical industry at every level, from exploiting the vulnerable destitute for drug testing, through manipulation of research data, to disease mongering and promoting drugs that do more harm than good. This is a brilliant expose of the negative influence of the global pharmaceutical industry.
Breaking bad
\"As one of the most critically acclaimed shows of all time, Breaking Bad explored the life and crimes of a high school chemistry teacher turned meth kingpin of the American Southwest. As Walter White and his former student Jesse Pinkman become deeply entwined in the drug world, their narrative leaves a trail of bodies strewn across the show's five seasons--a story that resulted in more than 15 Emmy awards. In Breaking Bad: A Cultural History, Lara C. Stache offers an engaging analysis of the program, focusing on the show's fascinating characters and complex story lines. Stache gives the show its due reverence, but also suggests new ways of understanding and critiquing the series as a part of the larger culture in which it exists. The author looks at how the program challenges viewers to think about the choices made in the narrative, analyzes what did and did not work, and determines the program's cultural significance, particularly its place in twenty-first century America. The author also explores how Breaking Bad grapples with themes of morality, legality, and anti-drug rhetoric and looks at how the marketing of the series influenced the ways in which television shows are now promoted. Breaking Bad: A Cultural History captures the spirit of the series and examines how the show had an impact on viewers like no other program. This book will be of interest to fans of the show as well as to scholars and students of television, media, and American popular culture.\"
The fox and the grapes: an Anglo-Irish perspective on conscientious objection to the supply of emergency hormonal contraception without prescription
2013
Emergency hormonal contraception (EHC) has been available from pharmacies in the UK without prescription for 11 years. In the Republic of Ireland this service was made available in 2011. In both jurisdictions the respective regulators have included ‘conscience clauses’, which allow pharmacists to opt out of providing EHC on religious or moral grounds providing certain criteria are met. In effect, conscientious objectors must refer patients to other providers who are willing to supply these medicines. Inclusion of such clauses leads to a cycle of cognitive dissonance on behalf of both parties. Objectors convince themselves of the existence of a moral difference between supply of EHC and referral to another supplier, while the regulators must feign satisfaction that a form of regulation lacking universality will not lead to adverse consequences in the long term. We contend that whichever of these two parties truly believes in that which they purport to must act to end this unsatisfactory status quo. Either the regulators must compel all pharmacists to dispense emergency contraception to all suitable patients who request it, or a pharmacist must refuse either to supply EHC or to refer the patient to an alternative supplier and challenge any subsequent sanctions imposed by their regulator.
Journal Article